This inventor holds 31 USPTO granted patents and 1 published patent application, primarily in Thrombosis Inhibitors. Top assignees: Corvas International, Inc., Dendreon Corporation. Active years: 1994-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-2008
Areas of Expertise:
Title: The Innovative Contributions of George Phillip Vlasuk
Introduction
George Phillip Vlasuk, a prolific inventor based in Carlsbad, California, holds an impressive portfolio of 31 patents. His pioneering work primarily focuses on methods of treating hemorrhagic diseases, showcasing a commitment to addressing critical health challenges through innovative solutions.
Latest Patents
Among his most notable patents is a method of treatment for hemorrhagic disease utilizing a factor VIIa/tissue factor inhibitor. This invention outlines techniques for treating hemorrhagic fevers by employing selective inhibitors that target factor VIIa and tissue factor. The therapeutic effects of these inhibitors include the amelioration and prevention of coagulopathy and inflammatory responses. Vlasuk has also explored certain proteins known as Nematode-Extracted Anticoagulant Proteins (NAPs) as part of his research. Other significant inhibitors analyzed include Tissue Factor Pathway Inhibitor (TFPI) and its analogs.
Career Highlights
Vlasuk has worked with renowned organizations such as Corvas International, Inc. and Dendreon Corporation, contributing his expertise in research and development. His extensive experience in these companies has enabled him to advance his innovative work in medical treatments, particularly in addressing bleeding disorders.
Collaborations
Throughout his career, George Phillip Vlasuk has collaborated with esteemed colleagues, including Matthew Moyle and Yves Rene LaRoche. These partnerships have been instrumental in fostering a collaborative environment that promotes innovation and further enhances the impact of his research efforts.
Conclusion
George Phillip Vlasuk stands out as a significant figure in the field of medical innovation. His dedication to developing treatments for hemorrhagic diseases through extensive research and collaborations has resulted in valuable patents that contribute to advancing healthcare solutions. As he continues to explore new frontiers in medical technology, the implications of his work promise to benefit countless patients facing severe health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile